快验保 2026年季度报告

Medifast, Inc. Securities registered pursuant to Section 12(b) of the Act: Medifast, Inc. and Subsidiaries Index Part 1 – Financial Information Item 1 – Financial Statements Condensed Consolidated Statements of Operations (unaudited) for the Three Months Ended March 31, 2026 and 2025Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) for the Three Months Ended March31, 2026 and 2025Condensed Consolidated Balance Sheets (unaudited) as of March 31, 2026 and December 31, 2025Condensed Consolidated Statements of Cash Flows (unaudited) for the Three Months Ended March 31, 2026 and 2025Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited) for the Three Months Ended March31, 2026 and 2025Notes to Condensed Consolidated Financial Statements (unaudited)Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations16Item 3 – Quantitative and Qualitative Disclosures about Market Risk22Item 4 – Controls and Procedures22 Part II – Other Information Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds24 MEDIFAST, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) MEDIFAST, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) MEDIFAST, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) MEDIFAST, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) MEDIFAST, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation -The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (“Medifast,” the “Company,” “we,” “us,” or “our”) included herein have been prepared in accordance withgenerally accepted accounting principles in the United States of America (“GAAP”) for interim reporting and pursuant to the rules andregulations of the Securities and Exchange Commission (the “SEC”). Accordingly, certain information and notes that are normallyrequired by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal,recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included The results of operations for the three months ended March 31, 2026 are not necessarily indicative of results that may be expected forthe fiscal year ending December31, 2026. The accompanying unaudited condensed consolidated financial statements should be read Presentation of Financial Statements -The unaudited condensed consolidated financial statements included herein include the Use of Estimates- The preparation of financial statements in conformity with GAAP requires management to make estimates andassumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the The Company is, from time to time, subject to a variety of litigation and similar proceedings that arise out of the ordinary course of itsbusiness. Based upon the Company’s experience, current information and applicable law, it does not believe that these proceedings andclaims will have a material adverse effect on its results of operations, financial position or liquidity. However, the results of legal Advertising Expense- The costs of advertising efforts are expensed as incurred. They are recorded in selling, general, andadministrative expense in the accompanying Condensed Consolidated Statements of Operations (Unaudited). Advertising expense, Assets Held for Sale- During the year ended December 31, 2024, the Company completed a supply chain optimization initiative withthe goal of aligning the Company’s distribution footprint with current demand levels. On June 28, 2024, the Company closed itsMaryland Distribution Center located in Ridgely, Maryland. The Company listed the Maryland Distribution Center building and landfor sale, and categorized those assets as held for sale. The net book value of the building and land was $1.4million. The assets wererecorded within prepaid expenses and other current assets on the consolidated balance sheets included in the 2025 Form 10-K. The Provision for Income Taxes- The Company computes its income tax provision for interim periods in accordance with ASC 740. Forinterim periods during the year ended December31, 2025, the Company calculated an annual effective tax rate and applied that rate toyear-to-date ordinary income or loss to calculate its quarterly income tax provision (“AETR Approach”). Due to the existence of a fullvaluation allowance against its deferred tax assets recorded as of December31, 2025, the Company did not apply the AETR Approachfor the period ended March31, 2026. Instead, the Company calculated income tax expense for the inte